Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

SVF-PRP therapy effectively reverses hair loss effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Pyoderma gangrenosum can occur in rheumatoid arthritis patients and may be mistaken for vasculitis.

QR678 Neo is more effective than PRP for hair growth and quality.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Exprecell™ is as effective as traditional methods but produces more f-PRF and is simpler to use.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Avicennia marina extract can significantly promote hair growth in androgenic alopecia patients.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

The project developed and tested a method using plasma rich platelets to treat hair loss.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Long-term oral and topical treatments improved skin condition in a goldendoodle with a genetic disorder.

PRP is unlikely to effectively treat wrist ganglia.

PRP injections improve knee function in osteoarthritis.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Deucravacitinib helped a man regrow hair significantly.

Pharmacists play a crucial role in patient education and personalized care.

AH-001 could be a safer and more effective treatment for hair loss.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

The treatment was not recommended due to limited effectiveness and significant side effects.

Shock wave therapy improved muscle function and movement in children with spastic cerebral palsy.

PRP may help with hair loss, but more research is needed.